PARIS, Mar. 05, 2026 -- FUJIFILM, a global provider of diagnostic and enterprise imaging solutions, has partnered with AZmed, one of the leading artificial intelligence (AI) companies in medical imaging, to integrate its complete Rayvolve® AI Suite into FUJIFILM's Synapse PACS. The first hospital to implement these integrated AI solutions is AZ Sint-Blasius in Dendermonde, Belgium.
Belgium ranks high in medical imaging utilization compared with other European countries. Due to an ageing population and the increasing importance of medical imaging, volumes are increasing steadily each year. Belgium also faces an inherent shortage of radiologists. The current training quotas permit only 25 physicians to begin radiology specialty training annually, while a large portion of the existing workforce is approaching retirement. This manpower challenge is mirrored across the Benelux; according to the EU‑REST study, 45% of radiologists are over 51, indicating that imaging departments will continue to face increasing workloads without a corresponding increase in personnel.
As imaging departments are addressing this issue, their selection of technology partners is even more critical. FUJIFILM has an established presence and long-standing relationships with its customers in the Benelux healthcare ecosystem and can offer a direct pathway to validated AI technology for adoption by radiology departments.
"Radiologists depend on us to provide solutions that enhance their clinical workflow," said Tim Uytterhoeven, Regional Director at FUJIFILM. "We are proud to work with AZmed, and through the Fujifilm AI Orchestrator, we can seamlessly integrate their Rayvolve® AI Suite directly into our Synapse PACS. We see a number of hospitals in Belgium, the Netherlands, and Luxembourg that will greatly benefit from this streamlined access to advanced AI tools."
"Radiologists can rely on the AI capabilities of the entire Rayvolve® Suite to deliver a wide range of applications to improve the radiological workflow, productivity, and care for patients. Thanks to the Fujifilm AI Orchestrator acting as a central hub, there is no new login or extra clicks. Every study will continue to be processed as soon as it is acquired, with no change to the current way of working for customers. This zero-friction activation provided by the Fujifilm AI Orchestrator is critical as radiology departments are already under extreme pressure," said Leander Taelman, Account Manager at FUJIFILM.
In August 2023, AZ Sint-Blasius deployed AZmed's AI fracture detection tool, AZtrauma. Following a successful six-month clinical evaluation, the hospital is now expanding to the complete Rayvolve® AI Suite. The suite consists of four CE-marked modules: AZtrauma for fracture and dislocation identification, AZchest for detection of thoracic pathologies, AZmeasure for automated measurement of musculoskeletal anatomy, and AZboneage for assessment of skeletal maturity in children.
Dr. Nicolas de Vos, Medical Head of the Radiology Department at AZ Sint-Blasius, commented, "The way in which we manage our workload has completely changed with the addition of the full Rayvolve® AI Suite. The ability to have abnormal findings flagged and prioritized provides us with more time in our clinical decision-making, as opposed to having to search for the abnormalities. Junior clinicians, working outside of core hours, have had their speed of workflow and level of confidence enhanced due to the use of AI. As a result, we are able to treat more patients without compromising on quality of care."
"AZ Sint-Blasius confirms what our clinical evidence continues to show. When AI is validated on hundreds of thousands of real-world examinations and delivered inside the tools radiologists already use, adoption is immediate and the impact is measurable," said Julien Vidal, CEO of AZmed. "With FUJIFILM's extensive reach, we will be able to bring our AI technology to every Synapse PACS location throughout the Benelux, and we intend to do just that."
FUJIFILM and AZmed are now looking to broaden their relationship to more sites; additionally, both companies will expand beyond the current X-ray analysis product to include AZmed's Rayscan® AI Suite, beginning with AZnod for pulmonary nodule detection on CT scans.
About AZmed:
Founded in 2018, AZmed is a European MedTech company developing AI solutions for medical imaging. Its Rayvolve® AI Suite includes FDA-cleared and CE-marked tools, while its Rayscan® line is CE-marked. Used by more than 2,500 healthcare facilities worldwide, AZmed’s solutions improve diagnostic consistency and operational efficiency in medical imaging. Additional resources on AI-supported fracture detection and chest imaging are available on AZmed’s website.
